Toll free

18002022232

Academic Sessions

Videos

Instagram Youtube Linkedin Facebook
Quick Links
Therapies
Reach Us
Our Centres

Mumbai (Thane, Khar) | Kerala (Thodupuzha) | Nashik

Email Support

[email protected]

Let's Talk

Phone: +91 86553 13412
Toll Free: 1800 202 2232

Copyright© 2025 SunAct. All rights reserved. Powered by Regisdigitals.
Disclaimer: The information on this website is for general knowledge purposes only and does not constitute medical advice, diagnosis, or treatment in any form. It is not a substitute for professional medical advice from a qualified physician. Additionally, you are browsing the official and only website of SunAct and not an agent or affiliate website.

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

proceed to call

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male